Status:
ACTIVE_NOT_RECRUITING
VERARE_2 Efficacy of the Observation of Virtual Motor Actions for the Improvement of Gait in Patients With ICU-weakness
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Equipe Hybrid, INRIA - Campus Universitaire de Beaulieu - F-35042 Rennes Cedex - France
Conditions:
ICU-weakness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
After hospitalization in Intensive Care (Intensive Care Unit or Continuing Care Unit), approximately 50% of patients usually present with intensive ICU-weakness, i.e. damage to the nerves and muscles ...
Eligibility Criteria
Inclusion
- Patient hospitalized in one of the ICU or Continuing Care Units or at the CHU de Rennes for less than 3 months, and presenting lower limb muscle weakness with MRC motor testing on the main muscle segments giving a score of less than or equal to 48/60 (ICU Weakness diagnostic criterion) in the aftermath of severe sepsis.
- Person of full age;
- Affiliation to a social security scheme;
- Free, informed and signed written consent.
Exclusion
- History of a central neurological event with clinical repercussions
- Gait disorders pre-existing to hospitalization in intensive care and limiting the walking perimeter (declaration by the patient) or requiring the use of technical assistance;
- Uncontrolled epilepsy (seizure less than 6 months old);
- Adults who are the subject of legal protection (safeguard of justice, curatorship, guardianship), persons deprived of their liberty;
- Non-French speaking person;
- Pregnant or breastfeeding woman.
Key Trial Info
Start Date :
March 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 2 2025
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04713345
Start Date
March 26 2021
End Date
September 2 2025
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rennes University Hospital
Rennes, Brittany Region, France, 35300